+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Coronavirus Drug Discovery. Volume 2: Antiviral Agents from Natural Products and Nanotechnological Applications. Drug Discovery Update

  • Book
  • July 2022
  • Elsevier Science and Technology
  • ID: 5576615

Coronavirus Drug Discovery, Volume Two: Antiviral Agents from Natural Products and Nanotechnological Applications presents detailed information on drug discovery against COVID-19. Sections in this volume present chapters that focus on the various antiviral agents from natural products that have the propensity to be used as chemical scaffolds for the development of drugs against COVID-19. Also captured are the dietary sources of antioxidant bioactives that may help boost the immune system for the management of COVID-19. Other chapters describe the application of nanotechnology for efficient and effective delivery of drugs against COVID-19.

Written by global team of experts, this book is an excellent resource for drug developers, medicinal chemists, pharmaceutical companies in R&D and research institutes in both academia and industry.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

PART I: ANTIVIRAL AGENTS FROM NATURAL PRODUCTS 1. COVID-19 management and phytomedicine interventions: Potentials and safety considerations 2. Plants with potent antiviral properties 3. Antiviral effects of medicinal plants and their active phytochemical constituents against respiratory diseases and associated biological functions 4. Herbs and drugs in clinical trials for coronavirus treatments 5. Herbal-Based Resources against Exanthematous Viral Infections and Other Viral Diseases 6. Dietary polyphenols as therapeutic agents to combat COVID-19 7. Bioactive compounds and herbal preparations implicated in for the treatment of SARS-CoV-2 8. Roles of Antioxidants in the Prevention and Management of Coronavirus Disease 2019 9. Food sources of natural antioxidants for body defence against SARS-CoV-2 10. Nutritional Management against Severe Acute Respiratory Syndrome Coronavirus-2 Infection

Authors

Chukwuebuka Egbuna chartered chemist and academic researcher. He is a member of the Institute of Chartered Chemists of Nigeria (ICCON), the Nigerian Society of Biochemistry and Molecular Biology (NSBMB), and the Royal Society of Chemistry (RSC) (United Kingdom).. Chukwuebuka Egbuna is a chartered chemist and academic researcher. He is a member of the Institute of Chartered Chemists of Nigeria (ICCON), the Nigerian Society of Biochemistry and Molecular Biology (NSBMB), and the Royal Society of Chemistry (RSC) (United Kingdom). Egbuna is the founder and editor of the Elsevier book series on Drug Discovery Update. The series includes books, monographs and edited collections from all areas of drug discovery including emerging therapeutic claims for the treatment of diseases. He has been engaged in a number of roles at New Divine Favor Pharmaceutical Industry Limited, Akuzor Nkpor, Anambra State, Nigeria, and Chukwuemeka Odumegwu Ojukwu University (COOU) in Nigeria. Egbuna has published research articles in many international journals of repute and is ranked among the top 500 Nigerian scientists in SciVal/SCOPUS. He has edited over 20 books with Elsevier, Springer, Wiley and Taylor & Francis. His most recent book is his 3 volume book on Coronavirus Drug Discovery published by Elsevier. Egbuna is the founder and the publishing director of IPS Intelligentsia Publishing Services. He is a reviewer and editorial board member of various journals. His primary research interests cut across biochemistry, phytochemistry, pharmacology, nutrition and toxicology, food and medicinal chemistry, and analytical biochemistry.